Riyad Seervai, MD, PhD

Physician-scientist, #StandardPoodle dad 🐩/ @brownuniversity '13 🐻/ @bcmhouston PhD '21, MD '22 👨🏽‍⚕️/ @provportland '23 / @OHSUSOM #derm '26 / views my own

[Riyad Seervai, MD, PhD @RSeervai]

@HarmitMalik @KamounLab "Went into industry"

[Riyad Seervai, MD, PhD @RSeervai]

Excited to be sharing some new work from @bcmhouston and @MDAndersonNews on immune-related BP at the #AAD2023 late-breaking research session this morning! #AAD23LATEBREAKER @mario_pathology @DrAldehyde @DrPhyuPAung2

[Riyad Seervai, MD, PhD @RSeervai]

@sargsyanz Invent SitaGLIiflozin

[Riyad Seervai, MD, PhD @RSeervai]

@fredhutch @flySEA @fhpatientcare @HarmitMalik @HutchBasicSci cardamom tea

[Riyad Seervai, MD, PhD @RSeervai]

This completes the triad of reviews of skin reactions to (1) immune checkpoint inhibitors, (2) small-molecule inhibitors, and (3) non-ICI mAbs

https://t.co/kRUCifmr0B

https://t.co/s75k9KkAPa

[Riyad Seervai, MD, PhD @RSeervai]

Our comprehensive survey of the dermatologic toxicities to monoclonal antibody cancer therapies now out in @JCutaneousPath!
#dermtwitter #oncoderm
@BCMFromtheLabs @MDAndersonNews @drdremchu @DrAldehyde @DrPhyuPAung2

https://t.co/3b6vcGN0Vs

[Riyad Seervai, MD, PhD @RSeervai]

We review and discuss reactions to 20+ different categories of non-ICI mAbs approved for the treatment of solid tumors and hematologic malignancies.

[Riyad Seervai, MD, PhD @RSeervai]

@jbcarmody Medical school becoming more and more like undergrad.
It is not just the pubs. There's an obsession with 'student groups' and there are people trying to start a group BEFORE even matriculating!

[Riyad Seervai, MD, PhD @RSeervai]

@RoxanaDaneshjou academia.

[Riyad Seervai, MD, PhD @RSeervai]

We review the current understanding of the immunopathogenesis of inflammatory, immunobullous, and pigment-related irAEs, experimental techniques to study these reactions, as well as lessons from work on non-cutaneous irAEs.

[Riyad Seervai, MD, PhD @RSeervai]

Happy to share our review on mechanisms of skin toxicities to immunotherapy in @ced_journal.
Thanks to Avilasha at @BCMFromtheLabs and Dr. Kulkarni at @OHSUKnight for helping to put this together!
#dermtwitter #immunotherapy
https://t.co/kbDrCsp6Ez

[Riyad Seervai, MD, PhD @RSeervai]

@MDJenniferChoi Congratulations!

[Riyad Seervai, MD, PhD @RSeervai]

@RoxanaDaneshjou Tiffany Blue

[Riyad Seervai, MD, PhD @RSeervai]

Sad sad news for #Houston and those who continue to live there. RIP Thai Gourmet, for me y'all were the best #Thai food establishment in North America 😭😭😭

[Riyad Seervai, MD, PhD @RSeervai]

@PhD_Genie Drove to Michigan, 1000 miles away from the lab.

[Riyad Seervai, MD, PhD @RSeervai]

@ChatrathSheena Food for thought - if an institution can't communicate whether or not they can have you for a 4-week rotation, what does that say about their culture, and is that somewhere you would want to invest your one-time training years?

[Riyad Seervai, MD, PhD @RSeervai]

@kmpanthagani Was there a control/unvacc¡nated sample for comparison?

[Riyad Seervai, MD, PhD @RSeervai]

@ESPNFC Fevernova

[Riyad Seervai, MD, PhD @RSeervai]

@DrJohnBarbieri @MishaRosenbach @JAADjournals Introducing the "reverse pearl."

[Riyad Seervai, MD, PhD @RSeervai]

Overjoyed to be continuing my journey with @clairewigginsmd in @Portland having matched to @ProvPortland prelim and @OHSUNews #derm! Pictured here with family in #Bombay behind my great great great grandfather - a royal court physician in #India.